98%
921
2 minutes
20
During the early phase of the COVID-19 pandemic, many respiratory therapies were classified as aerosol-generating procedures. This categorization resulted in a broad range of clinical concerns and a shortage of essential medical resources for some patients. In the past 2 years, many studies have assessed the transmission risk posed by various respiratory care procedures. These studies are discussed in this narrative review, with recommendations for mitigating transmission risk based on the current evidence.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4187/respcare.10160 | DOI Listing |
Bioinformation
May 2025
Department of Periodontics, Rayat bahara Dental College and Hospital, Mohali Punjab, India.
The COVID-19 pandemic severely disrupted postgraduate (PG) teaching in periodontology, affecting academic learning, clinical training, and research productivity. While online education enhanced theoretical knowledge, restrictions on aerosol-generating procedures limited hands-on experience, especially in surgical training and implantology. A cross-sectional survey among PG students and faculty highlighted decreased clinical exposure, reduced research opportunities, and increased trainee stress.
View Article and Find Full Text PDFBr Dent J
August 2025
UNICA, Caries Research Unit, Research Department, Universidad El Bosque, Bogotá, Colombia.
Introduction CariesCare International (CCI) is a practice-friendly, health outcomes-focused, patient-centred, risk-based approach to caries management designed for the practice. The unfeasibility of a randomised clinical trial and of aerosol generating procedures (AGPs) during the COVID-19 pandemic to test the caries control effectiveness of CCI shifted it to a non-AGP, reduced on-site consultation, single-interventional study.Aim This 12-month, multicentre, single-group, interventional study aimed at primarily assessing the control of caries progression of a pandemic CCI-adapted protocol in children.
View Article and Find Full Text PDFCureus
July 2025
Basic Science Education, Virginia Tech Carilion School of Medicine, Roanoke, USA.
Context In the early months of the COVID-19 pandemic, polymerase chain reaction (PCR) testing for SARS-CoV-2 was difficult to obtain and took several days to return a result. Our health system wished to explore the use of the Quidel Sofia (Quidel Corporation, San Diego, CA) antigen test to diagnose COVID-19 in our primary care clinics, but the test was approved for emergency use authorization by the US Food and Drug Administration (FDA) with only 250 test subjects. In addition, because it was important to avoid aerosol-generating procedures in primary care clinics, it was necessary to test the diagnostic performance of the antigen test using mid-turbinate (MT) swabs rather than the approved nasopharyngeal (NP) swab technique.
View Article and Find Full Text PDFLaryngoscope
July 2025
NYU Voice & Swallowing Center, Department of Otolaryngology-Head and Neck Surgery, NYU Grossman School of Medicine, New York, New York, USA.
Objective: Surgical treatment of recurrent respiratory papillomatosis (RRP) has been shown to aerosolize human papillomavirus (HPV), putting healthcare workers at risk for exposure, infection, and disease. Knowledge of HPV infection risk among otolaryngologists who treat HPV-related diseases is limited. We sought to characterize the prevalence of oral HPV infection in otolaryngologists treating RRP.
View Article and Find Full Text PDFSci Rep
July 2025
Department of Pediatric Anesthesia, BC Children's Hospital, University of British Columbia, Vancouver, Canada.